313 related articles for article (PubMed ID: 19940225)
1. Projecting the future diabetes population size and related costs for the U.S.
Huang ES; Basu A; O'Grady M; Capretta JC
Diabetes Care; 2009 Dec; 32(12):2225-9. PubMed ID: 19940225
[TBL] [Abstract][Full Text] [Related]
2. Economic costs of diabetes in the U.S. In 2007.
American Diabetes Association
Diabetes Care; 2008 Mar; 31(3):596-615. PubMed ID: 18308683
[TBL] [Abstract][Full Text] [Related]
3. Projection of Diabetes Population Size and Associated Economic Burden through 2030 in Iran: Evidence from Micro-Simulation Markov Model and Bayesian Meta-Analysis.
Javanbakht M; Mashayekhi A; Baradaran HR; Haghdoost A; Afshin A
PLoS One; 2015; 10(7):e0132505. PubMed ID: 26200913
[TBL] [Abstract][Full Text] [Related]
4. Economic Costs of Diabetes in the U.S. in 2017.
American Diabetes Association
Diabetes Care; 2018 May; 41(5):917-928. PubMed ID: 29567642
[TBL] [Abstract][Full Text] [Related]
5. Use of the National Health and Nutrition Examination Survey to calculate the impact of obesity and diabetes on cost and prevalence of urolithiasis in 2030.
Antonelli JA; Maalouf NM; Pearle MS; Lotan Y
Eur Urol; 2014 Oct; 66(4):724-9. PubMed ID: 25015037
[TBL] [Abstract][Full Text] [Related]
6. Economic Costs of Diabetes in the U.S. in 2022.
Parker ED; Lin J; Mahoney T; Ume N; Yang G; Gabbay RA; ElSayed NA; Bannuru RR
Diabetes Care; 2024 Jan; 47(1):26-43. PubMed ID: 37909353
[TBL] [Abstract][Full Text] [Related]
7. The economic burden of diabetes.
Dall TM; Zhang Y; Chen YJ; Quick WW; Yang WG; Fogli J
Health Aff (Millwood); 2010 Feb; 29(2):297-303. PubMed ID: 20075080
[TBL] [Abstract][Full Text] [Related]
8. Projection of the burden of type 2 diabetes mellitus in Germany: a demographic modelling approach to estimate the direct medical excess costs from 2010 to 2040.
Waldeyer R; Brinks R; Rathmann W; Giani G; Icks A
Diabet Med; 2013 Aug; 30(8):999-1008. PubMed ID: 23506452
[TBL] [Abstract][Full Text] [Related]
9. Projecting Long-term Health and Economic Burden of COPD in the United States.
Zafari Z; Li S; Eakin MN; Bellanger M; Reed RM
Chest; 2021 Apr; 159(4):1400-1410. PubMed ID: 33011203
[TBL] [Abstract][Full Text] [Related]
10. Relation of body mass index in young adulthood and middle age to Medicare expenditures in older age.
Daviglus ML; Liu K; Yan LL; Pirzada A; Manheim L; Manning W; Garside DB; Wang R; Dyer AR; Greenland P; Stamler J
JAMA; 2004 Dec; 292(22):2743-9. PubMed ID: 15585734
[TBL] [Abstract][Full Text] [Related]
11. Obesity prevalence in Mexico: impact on health and economic burden.
Rtveladze K; Marsh T; Barquera S; Sanchez Romero LM; Levy D; Melendez G; Webber L; Kilpi F; McPherson K; Brown M
Public Health Nutr; 2014 Jan; 17(1):233-9. PubMed ID: 23369462
[TBL] [Abstract][Full Text] [Related]
12. The cost of diabetes in Canada over 10 years: applying attributable health care costs to a diabetes incidence prediction model.
Bilandzic A; Rosella L
Health Promot Chronic Dis Prev Can; 2017 Feb; 37(2):49-53. PubMed ID: 28273040
[TBL] [Abstract][Full Text] [Related]
13. Implications of population growth on prevalence of diabetes. A look at the future.
Helms RB
Diabetes Care; 1992 Mar; 15 Suppl 1():6-9. PubMed ID: 1559424
[TBL] [Abstract][Full Text] [Related]
14. Economic Costs Attributable to Diabetes in Each U.S. State.
Shrestha SS; Honeycutt AA; Yang W; Zhang P; Khavjou OA; Poehler DC; Neuwahl SJ; Hoerger TJ
Diabetes Care; 2018 Dec; 41(12):2526-2534. PubMed ID: 30305349
[TBL] [Abstract][Full Text] [Related]
15. The current total economic burden of diabetes mellitus in the Netherlands.
Peters ML; Huisman EL; Schoonen M; Wolffenbuttel BHR
Neth J Med; 2017 Sep; 75(7):281-297. PubMed ID: 28956787
[TBL] [Abstract][Full Text] [Related]
16. The cost of diabetes in adults in Australia.
Lee CM; Colagiuri R; Magliano DJ; Cameron AJ; Shaw J; Zimmet P; Colagiuri S
Diabetes Res Clin Pract; 2013 Mar; 99(3):385-90. PubMed ID: 23298663
[TBL] [Abstract][Full Text] [Related]
17. Repaglinide : a pharmacoeconomic review of its use in type 2 diabetes mellitus.
Plosker GL; Figgitt DP
Pharmacoeconomics; 2004; 22(6):389-411. PubMed ID: 15099124
[TBL] [Abstract][Full Text] [Related]
18. The economic burden of elevated blood glucose levels in 2012: diagnosed and undiagnosed diabetes, gestational diabetes mellitus, and prediabetes.
Dall TM; Yang W; Halder P; Pang B; Massoudi M; Wintfeld N; Semilla AP; Franz J; Hogan PF
Diabetes Care; 2014 Dec; 37(12):3172-9. PubMed ID: 25414388
[TBL] [Abstract][Full Text] [Related]
19. Economic consequences of diabetes mellitus in the U.S. in 1997. American Diabetes Association.
Diabetes Care; 1998 Feb; 21(2):296-309. PubMed ID: 9539999
[TBL] [Abstract][Full Text] [Related]
20. [Heterogeneity of costs of diabetic patients: the Cost of Diabetes Mellitus Study].
Köster I; Hauner H; von Ferber L
Dtsch Med Wochenschr; 2006 Apr; 131(15):804-10. PubMed ID: 16607599
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
